Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation.

[1]  L. Ellis,et al.  Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. , 2003, Cancer research.

[2]  F. Sundler,et al.  Local Growth Factors Are Beneficial for the Autonomic Reinnervation of Transplanted Islets in Rats , 2003, Pancreas.

[3]  H. Hammes,et al.  Angiogenic capacity of endothelial cells in islets of Langerhans , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  T. Flotte,et al.  Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice. , 2003, Diabetes.

[5]  S. Nock,et al.  Recent developments in protein microarray technology. , 2003, Angewandte Chemie.

[6]  K. Ekdahl,et al.  Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation , 2002, The Lancet.

[7]  R. Barry,et al.  Reproducibility of targeted gene expression measurements in human islets of Langerhans. , 2002, Biochemical and biophysical research communications.

[8]  R. Busuttil,et al.  Heme oxygenase-1 system in organ transplantation1 , 2002 .

[9]  S. Sandler,et al.  Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo. , 2002, European journal of endocrinology.

[10]  D. Harlan,et al.  Oligonucleotide Microarray Analysis of Intact Human Pancreatic Islets: Identification of Glucose-Responsive Genes and a Highly Regulated TGFβ Signaling Pathway , 2002 .

[11]  C. Mathieu,et al.  A View on Beta Cell Transplantation in Diabetes , 2002, Annals of the New York Academy of Sciences.

[12]  A. M. Shapiro,et al.  Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice , 2002, Diabetologia.

[13]  O. Korsgren,et al.  DIABETIC RATS TRANSPLANTED WITH ADULT PORCINE ISLETS AND IMMUNOSUPPRESSED WITH CYCLOSPORINE A, MYCOPHENOLATE MOFETIL, AND LEFLUNOMIDE REMAIN NORMOGLYCEMIC FOR UP TO 100 DAYS1 , 2001, Transplantation proceedings.

[14]  G. Steil,et al.  GENE EXPRESSION OF VEGF AND ITS RECEPTORS Flk-1/KDR AND Flt-1 IN CULTURED AND TRANSPLANTED RAT ISLETS1 , 2001, Transplantation.

[15]  M. Menger,et al.  Revascularization and Microcirculation of Freely Grafted Islets of Langerhans , 2001, World Journal of Surgery.

[16]  A. Andersson,et al.  Melatonin protects against streptozotocin, but not interleukin‐1β‐induced damage of rodent pancreatic β‐cells , 2001, Journal of pineal research.

[17]  C. Mathieu,et al.  Monocyte chemoattractant protein-1 is expressed in pancreatic islets from prediabetic NOD mice and in interleukin-1β-exposed human and rat islet cells , 2001, Diabetologia.

[18]  H. Dvorak,et al.  Differential expression of thymosin β‐10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  E. Ryan,et al.  Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.

[20]  P. Reitz,et al.  Effects of diabetes and hypoxia on gene markers of angiogenesis (HGF, cMET, uPA and uPAR, TGF-α, TGF-β, bFGF and Vimentin) in cultured and transplanted rat islets , 2000, Diabetologia.

[21]  D. Steiner,et al.  Expression profiling of pancreatic beta-cells: glucose regulation of secretory and metabolic pathway genes. , 2000, Diabetes.

[22]  F. Schuit,et al.  Identification of IL-1β-induced messenger RNAs in rat pancreatic beta cells by differential display of messenger RNA , 1999, Diabetologia.

[23]  W. Hanlon,et al.  Enzymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. , 1999, Biochemistry.

[24]  G. Viglietto,et al.  Thymosin β-10 Gene Overexpression Is a General Event in Human Carcinogenesis , 1999 .

[25]  S. Efrat,et al.  Genes induced by growth arrest in a pancreatic β cell line: identification by analysis of cDNA arrays , 1999, FEBS letters.

[26]  G. Korbutt,et al.  Intraductal Collagenase Delivery into the Human Pancreas Using Syringe Loading or Controlled Perfusion , 1999, Transplantation proceedings.

[27]  L. Leondiadis,et al.  Investigation of the epitopic structure of thymosin β10 by epitope mapping experiments , 1999, Peptides.

[28]  G. Neufeld,et al.  Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  B. Hering,et al.  Assessment of intracellular insulin content during all steps of human islet isolation procedure. , 1998, Cell transplantation.

[30]  P. Carmeliet,et al.  Vascular development and disorders: molecular analysis and pathogenic insights. , 1998, Kidney international.

[31]  J. Haefliger,et al.  Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  L. Orci,et al.  Vascular endothelial growth factor is increased in devascularized rat islets of Langerhans in vitro. , 1997, Transplantation.

[33]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[34]  R. Bucala,et al.  An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Mori,et al.  Colocalization of vascular endothelial growth factor (vascular permeability factor) and insulin in pancreatic islet cells. , 1995, The Journal of clinical endocrinology and metabolism.

[36]  Camillo Ricordi,et al.  Automated Method for Isolation of Human Pancreatic Islets , 1988, Diabetes.

[37]  T. Emery,et al.  Peptides , 1964, Peptides.

[38]  A. S. Wiener,et al.  Transplantation , 1963 .

[39]  P. Allavena,et al.  Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. , 2002, Diabetes.

[40]  M. Saraste,et al.  FEBS Lett , 2000 .

[41]  D. Schurman,et al.  Chemotaxis and activation of particle-challenged human monocytes in response to monocyte migration inhibitory factor and C-C chemokines. , 1999, Journal of biomedical materials research.

[42]  Pei-shan Wu,et al.  Biochemical and Biophysical Research Communications , 1960, Nature.